Shockwave Confirms Consistent Outcomes for IVL in the Largest Prospective Real World Study of Patients with Heavily Calcified Peripheral Arterial Disease Seite 1

01.11.2022 - Disrupt PAD III Observational Study Results Confirm Safety and Effectiveness of IVL in Patients with Complex Calcified LesionsLAS VEGAS, Nov. 01, 2022 (GLOBE NEWSWIRE) - Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of ... Seite 1

Related Keywords

Ehrinj Armstrong , ,Vascular Institute ,Medical Director ,Adventist Heart ,Typed F ,